Search Team

Search by Last Name

Wireless Medical Devices Conference 2014

December 30, 2014

Wireless Medical Devices Conference 2014

December 30, 2014

Home » Resources » Blogs

From December 3-4, the San Jose convention center was transformed into the epicenter of the digital health world, with hundreds of attendees gathering at the MedTechWorld BIOMEDevice “Wireless Medical Devices Conference.” The exhibit floor was quaking with both entrepreneurs and more established companies showing off their latest products and services.

Andrew Atwell, of Samsung Open Innovation Center, presented the keynote address on the wireless frontier, and discussed prospects for merging medical and non-medical innovation. Other speakers addressed the Internet of Things, and communications that migrate from the hospital, to the home, and beyond. Mr. Eddy Lee, a Consulting Assistant Professor at Stanford University, surveyed the wide variety of mobile sensor devices that are available, impressing the audience with the scope of the technology.

Bakul Patel, the FDA’s Senior Policy Advisor on digital health, provided an address on a range of digital health issues via a remote connection from Washington, D.C. Mr. Patel focused on the need to improve interoperability and security of software-based devices. He also stressed that the international regulatory community is moving away from the term “stand alone software” and instead gravitating towards “software as a medical device,” and that the location of the software is not important to its regulatory status.

Fish & Richardson, a sponsor of the event, provided legal insight in two of the many separate educational sessions offered as part of the conference. Our first presentation discussed the evolving FCC and FDA regulation of wireless devices, including medical apps, and the impact of the joint FCC/FDA/ONC report on Health IT. App developers in particular need to be aware of when the FDA considers software to be a regulated medical device, potentially subject to premarket clearance from the FDA, and possibly even clinical trials to prove safety and effectiveness. Our second presentation focused on the challenges that digital health companies face in protecting their intellectual property, particularly in light of recent court decisions on the patentability of software. Other speakers covered wireless infrastructure, wireless product development and design, biocompatibility, data security and privacy, wireless power transfer, and electronic health records.

Whether calling it mHealth, telemedicine, or digital health, there is no doubt that wireless technologies will continue to transform the healthcare industry, including how medical devices are designed, how providers deliver care to patients, and how patients interact with care givers and manage their conditions. Many gray areas and challenges remain, and companies need to stay abreast of this rapidly developing area of law.

For more information about the emerging field of digital health, see:

Fish & Richardson’s Digital Health Services

Authors: Keith A. Barritt, Tamara Fraizer, Ph.D.

The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.

Blog Authors

Keith Barritt | Trademark Attorney - Washington, DC
Keith A. Barritt | Principal

Keith A. Barritt is a principal in the Washington, D.C., office of Fish & Richardson P.C. His practice is primarily focused on all aspects of trademark law, including prosecution and inter partes proceedings before the U.S. Patent and Trademark Office, internet domain name issues, and trademark selection and enforcement, as well as all...